No Data
No Data
Scotiabank Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Adaptive Biotechnologies (ADPT) and Rezolute (RZLT)
Scotiabank Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)
Express News | Adaptive Biotechnologies Corp : Piper Sandler Raises Target Price to $6 From $5
Morgan Stanley Maintains Adaptive Biotechnologies(ADPT.US) With Hold Rating, Maintains Target Price $7
Express News | JP Morgan Maintains Overweight on Adaptive Biotechnologies, Raises Price Target to $6
No Data